Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kenneth I Ataga

Showing results (41-50 of 133) with videos related to

Pageof 14
Sort By:
The Journal of Biological Chemistry|August 5, 2004
Mechanism of CD47-induced alpha4beta1 integrin activation and adhesion in sickle reticulocytesJulia E Brittain, Jaewon Han, Kenneth I Ataga, et al.
British Journal of Haematology|November 22, 2018
Effect of renin-angiotensin-aldosterone system blocking agents on progression of glomerulopathy in sickle cell diseaseAshley Thrower, Emily J Ciccone, Poulami Maitra, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|April 8, 2006
Biologically active CD40 ligand is elevated in sickle cell anemia: potential role for platelet-mediated inflammationSheritha P Lee, Kenneth I Ataga, Eugene P Orringer, et al.
British Journal of Haematology|April 22, 2008
Fibronectin bridges monocytes and reticulocytes via integrin alpha4beta1Julia E Brittain, Christine M Knoll, Kenneth I Ataga, et al.
The American Journal of Cardiology|February 21, 2012
Hemodynamic characteristics and predictors of pulmonary hypertension in patients with sickle cell diseaseMelissa C Caughey, Alan L Hinderliter, Susan K Jones, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|October 3, 2013
Hydroxyurea is associated with lower prevalence of albuminuria in adults with sickle cell diseaseLouis-Philippe Laurin, Patrick H Nachman, Payal C Desai, et al.
British Journal of Haematology|October 3, 2022
Patients with sickle cell disease who develop end-stage kidney disease continue to experience poor survival - A 19-year United States Renal Data System studyJeffrey C Winer, Marianne E Yee, Kenneth I Ataga, et al.
The American Surgeon|July 9, 2018
An Interdisciplinary Perioperative Management Protocol for Patients with Sickle Cell Anemia: A Single-Surgeon ExperienceSara Scarlet, Raeshell S Sweeting, Kenneth I Ataga, et al.
Plos One|April 4, 2020
Low hemoglobin increases risk for cerebrovascular disease, kidney disease, pulmonary vasculopathy, and mortality in sickle cell disease: A systematic literature review and meta-analysisKenneth I Ataga, Victor R Gordeuk, Irene Agodoa, et al.
British Journal of Haematology|March 13, 2018
Renal protection by atorvastatin in a murine model of sickle cell nephropathyRima S Zahr, Prasanthi Chappa, Hong Yin, et al.
Pageof 14

Showing results (41-50 of 133) with videos related to

Sort By:
Pageof 14
The Journal of Biological Chemistry|August 5, 2004
Mechanism of CD47-induced alpha4beta1 integrin activation and adhesion in sickle reticulocytesJulia E Brittain, Jaewon Han, Kenneth I Ataga, et al.
British Journal of Haematology|November 22, 2018
Effect of renin-angiotensin-aldosterone system blocking agents on progression of glomerulopathy in sickle cell diseaseAshley Thrower, Emily J Ciccone, Poulami Maitra, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|April 8, 2006
Biologically active CD40 ligand is elevated in sickle cell anemia: potential role for platelet-mediated inflammationSheritha P Lee, Kenneth I Ataga, Eugene P Orringer, et al.
British Journal of Haematology|April 22, 2008
Fibronectin bridges monocytes and reticulocytes via integrin alpha4beta1Julia E Brittain, Christine M Knoll, Kenneth I Ataga, et al.
The American Journal of Cardiology|February 21, 2012
Hemodynamic characteristics and predictors of pulmonary hypertension in patients with sickle cell diseaseMelissa C Caughey, Alan L Hinderliter, Susan K Jones, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|October 3, 2013
Hydroxyurea is associated with lower prevalence of albuminuria in adults with sickle cell diseaseLouis-Philippe Laurin, Patrick H Nachman, Payal C Desai, et al.
British Journal of Haematology|October 3, 2022
Patients with sickle cell disease who develop end-stage kidney disease continue to experience poor survival - A 19-year United States Renal Data System studyJeffrey C Winer, Marianne E Yee, Kenneth I Ataga, et al.
The American Surgeon|July 9, 2018
An Interdisciplinary Perioperative Management Protocol for Patients with Sickle Cell Anemia: A Single-Surgeon ExperienceSara Scarlet, Raeshell S Sweeting, Kenneth I Ataga, et al.
Plos One|April 4, 2020
Low hemoglobin increases risk for cerebrovascular disease, kidney disease, pulmonary vasculopathy, and mortality in sickle cell disease: A systematic literature review and meta-analysisKenneth I Ataga, Victor R Gordeuk, Irene Agodoa, et al.
British Journal of Haematology|March 13, 2018
Renal protection by atorvastatin in a murine model of sickle cell nephropathyRima S Zahr, Prasanthi Chappa, Hong Yin, et al.
Pageof 14